A number of NFκB target genes, including cytokines, cell cycle regulators, anti-apoptotic proteins and cell adhesion molecules, have been proposed to influence the invasion capacity and resistance to chemotherapy of GBM cells. This evidence concerns the gene NFKB1 and glioblastoma.